BDI Pharma takes pride in helping these smaller, yet vital, clinics not only stay afloat but, through our unique programs and pricing strategies, to actually thrive in today’s environment.
Columbia, SC (PRWEB) March 30, 2012
BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of specialty biotech therapies, celebrates the second (2nd) and third (3rd) year anniversaries, respectively, of the company’s savings and security based purchasing/rewards programs - QORe and SecuriGAM. These innovative product access initiatives were born out of BDI’s understanding of and concern for the pressures and struggles facing America’s private practice and small to medium sized medical clinics. As a private company itself, founded over 17 years ago, BDI Pharma embodies its company slogan of “More than a product and a price” through these types of programs and services targeted towards assisting even the most embattled of medical practices. QORe and SecuriGAM exemplify BDI’s commitment to provide solutions to this significant sector of healthcare provider.
“The small/medium sized practices scratch and claw every day for survival so that they don’t follow the trend of being absorbed by the local hospital. With reimbursement issues, the high cost of products, pressure to keep infusion chairs full and product supply issues, BDI Pharma takes pride in helping these smaller, yet vital, clinics not only stay afloat but, through our unique programs and pricing strategies, to actually thrive in today’s environment,” stated Tom Duffy, Director of Vaccine Portfolio at BDI.
“Much like so many of our customers, the ongoing challenge for BDI has been to compete with entities far larger in scale than itself – multiple divisions of billion dollar wholesalers. We have met this challenge with not only a passion but a strategy unmatched by anyone in our industry” offered Brad Davis, Assistant Vice President of Marketing for BDI. “We strive to demonstrate the growing relevance of the private practice and independent clinics on a daily basis to our manufacturing partners to ensure that their business model remains viable in even the toughest of times.”
About BDI Pharma, Inc.
Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent-need delivery. An open-access resource for reference material, educational literature, market data and online ordering, bdipharma.com (ivig.com) has become an industry-renowned point of reference. Proprietary programs for specialty veterinarians -- 4legpharma.com; product consignment -- consignadvantage.com; flu pre-booking and general vaccine ordering -- securivax.com; and purchasing/reward programs -- qoreprogram.com and securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.
BDI Pharma’s portfolio includes branded and generic specialty biopharmaceuticals, chemotherapy and supportive care products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.